ClinVar Miner

Submissions for variant NM_005859.5(PURA):c.123_146del (p.Gly42_Gly49del)

dbSNP: rs750397204
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000548116 SCV000655464 likely benign PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome 2024-01-08 criteria provided, single submitter clinical testing
GeneDx RCV001358641 SCV001791062 likely benign not provided 2018-12-10 criteria provided, single submitter clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System RCV001358641 SCV001554435 likely benign not provided no assertion criteria provided clinical testing The PURA p.Gly42_Gly49del variant was not identified in the literature but was identified in dbSNP (ID: rs1014354489) and ClinVar (classified as likely benign by Invitae). The variant was identified in control databases in 5 of 35864 chromosomes at a frequency of 0.0001394 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: South Asian in 2 of 1530 chromosomes (freq: 0.001307) and European (non-Finnish) in 3 of 18170 chromosomes (freq: 0.000165), but was not observed in the African, Latino, Ashkenazi Jewish, East Asian, European (Finnish), or Other populations. This is greater than the expected frequency for the severe, early-onset autosomal dominant PURA-Related Neurodevelopmental Disorders. This variant is an in-frame deletion resulting in the removal of glycine (gly) residues from codon 42 to 49; the impact of this alteration on PURA protein function is not known however this occurs within a glycine repeat region. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.